Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Forensic Toxicology
Published in: Forensic Toxicology 1/2018

01-01-2018 | Review Article

Furanylfentanyl: another fentanyl analogue, another hazard for public health

Authors: Nektaria Misailidi, Ioannis Papoutsis, Panagiota Nikolaou, Maria Katselou, Chara Spiliopoulou, Sotiris Athanaselis

Published in: Forensic Toxicology | Issue 1/2018

Login to get access

Abstract

The fentanyls are a family of drugs that have caused hundreds of deaths in Europe and the United States. They first appeared in the United States in the late 1970s; they were sold as heroin to unsuspecting users. Furanylfentanyl is a potent synthetic drug, an analogue of fentanyl that belongs to the above family. It has no proven medical use, but it is abused throughout the world for its opioid-like effects. The drug is mainly manufactured in China and is distributed worldwide. It is used mainly intranasally, but other routes of administration have also been reported. Furanylfentanyl has been involved in many intoxication cases, fatal or not, and many seizures of the drug have been recorded. The aim of this review is to summarize all the available information on furanylfentanyl, concerning its chemistry, synthesis, prevalence, metabolism, pharmacology, and toxicology, as well as its legal status. Analytical methods for the determination of furanylfentanyl in biological specimens are presented. Intoxications and lethal cases published in the scientific literature or reported on the web are also reviewed.
Literature
1.
2.
3.
4.
Gergov M, Nokua E, Vuori E, Ojanperä I (2009) Simultaneous screening and quantification of 25 opioid drugs in post-mortem blood and urine by liquid chromatography-tandem mass spectrometry. Forensic Sci Int 186:36–43CrossRefPubMed
5.
Helander A, Backberg M, Beck O (2016) Intoxications involving the fentanyl analogs acetylfentanyl, 4-methxybutyrfetnanyl and furanylfentanyl: results from the Swedish STRIDA project. Clin Toxicol 28:1–9
6.
Mohr ALA, Friscia M, Papsun D, Kacinko SL, Buzby D, Logan BK (2016) Analysis of novel synthetic opioids U-47700, U-50488 and furanyl fentanyl by LC–MS/MS in postmortem casework. J Anal Toxicol 40:709–717PubMed
7.
Klar SA, Brodkin E, Gibson E, Padhi S, Predy C, Green C, Lee V (2016) Furanyl-fentanyl overdose events caused by smoking contaminated crack cocaine—British Columbia. Canada, July 15–18, 2016. Health Promot Chronic Dis Prev Can 36:200–201CrossRefPubMedCentral
8.
Drug Enforcement Administration (DEA) Department of Justice (2016) Schedules of controlled substances: temporary placement of furanyl fentanyl into schedule I. Fed Regist 81:66224–66227
9.
Guerrieri D, Rapp E, Roman M, Druid H, Kronstrand R (2017) Postmortem and toxicological findings in a series of furanylfentanyl-related deaths. J Anal Toxicol 41:242–249PubMed
10.
11.
12.
Huang BS, Terrell RC, Deutsche KH, Kudzma LV, Lalinde NL (1986) N-Aryl-N-(4-piperidinyl) amides and pharmaceutical compositions and method employing such compounds. Patent US4584303, Part of US application Ser. No. 598,769 filed Apr 9, 1984
13.
Bagley JR, Wynn RL, Rudo FG, Doorley BM, Spenser HK, Spaulding T (1989) New 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties. J Med Chem 32:663–671CrossRefPubMed
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Europol 2015: annual report on the implementation of council decision 2005/387/JHA, ISSN 1977-7841. doi: 10.​2810/​932574
43.
Czech Republic Government, JUSTIFICATION, General Part (2016) Explanation of the need for the draft legislation, justification of its main principles, assessment of the current legal situation, and justification of the need to change it. IND- 2016 0565 CZ- EN- 20161102 IMPACT
44.
Helander A, Backberg M, Signell P, Beck O (2017) Intoxications involving acrylfentanyl and other novel designer fentanyls—results from the Swedish STRIDA project. Clin Toxicol 55:589–599CrossRef
45.
46.
47.
48.
49.
50.
51.
52.
53.
Goggin MM, Nguyen A, Janis GC (2017) Identification of unique metabolites of the designer opioid furanyl fentanyl. J Anal Toxicol 41:367–375CrossRefPubMed
54.
Watanabe S, Vikingsson S, Roman M, Green H, Kronstrand R, Wohlfarth A (2017) In vitro and in vivo metabolite identification studies for the new synthetic opioids acetylfentanyl, acrylfentanyl, furanylfentanyl, and 4-fluoro-isobutyrylfentanyl. AAPS J. doi:10.​1208/​s12248-017-0070-z
55.
56.
57.
Henderson GL, Harkey MR, Jones AD (1990) Rapid screening of fentanyl (China White) powder samples by solid-phase radioimmunoassay. J Anal Toxicol 14:172–175CrossRefPubMed
58.
Ruangyuttikarn W, Law MY, Rollins DE, Moody DE (1990) Detection of fentanyl and its analogs by enzyme-linked immunosorbent assay. J Anal Toxicol 14:160–164CrossRefPubMed
59.
Lucyk SN, Nelson LS (2016) Novel synthetic opioids: an opioid epidemic within an opioid epidemic. Ann Emerg Med 69:91–93CrossRefPubMed
60.
Al-Saffar Y, Stephanson NN, Beck O (2013) Multicomponent LC–MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the Swedish population. J Chromatogr B 930:112–120CrossRef
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
Polish Government (2011) file:///C:/Users/user/Downloads/Act%20amending%20the%20Act%20on%20counteracting%20drug%20addiction%20and%20the%20Act%20on%20State%20Sanitary%20Inspection.pdf. Accessed 08 May 2017
71.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2016) 45th Scientific Committee Meeting. Accessed 10–11 Nov 2016
Metadata
Title
Furanylfentanyl: another fentanyl analogue, another hazard for public health
Authors
Nektaria Misailidi
Ioannis Papoutsis
Panagiota Nikolaou
Maria Katselou
Chara Spiliopoulou
Sotiris Athanaselis
Publication date
01-01-2018
Publisher
Springer Japan
Published in
Forensic Toxicology / Issue 1/2018
Print ISSN: 1860-8965
Electronic ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-017-0371-z

Other articles of this Issue 1/2018

Forensic Toxicology 1/2018 Go to the issue

Letter to the Editor

A modified direct-heating headspace solid-phase microextraction method for drug screening with urine samples

Review Article

Fentanyls continue to replace heroin in the drug arena: the cases of ocfentanil and carfentanil

Short Communication

Spectroscopic characterization and crystal structures of two cathinone derivatives: 1-(4-chlorophenyl)-2-(1-pyrrolidinyl)-pentan-1-one (4-chloro-α-PVP) sulfate and 1-(4-methylphenyl)-2-(dimethylamino)-propan-1-one (4-MDMC) hydrochloride salts, seized on illicit drug market

Correction

Correction to: Analysis of toxic Veratrum alkaloids in plant samples from an accidental poisoning case

Review Article

The newest cathinone derivatives as designer drugs: an analytical and toxicological review

Erratum

Erratum to: Earwax as an alternative specimen for forensic analysis